IC-31 seasonal influenza vaccine (Intercell)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIC-31 seasonal influenza vaccine (Intercell)

Drug Alias NameIC 31 seasonal influenza vaccine (CSL/Valneva)IC 31 seasonal influenza vaccine-CSL/ValnevaIC-31 flu vaccine (Intercell/Novartis)Seasonal trivalent influenza vaccine (CSL/Valneva)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIntercell

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIntercell Novartis Pharma Ag

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A